Generalizability of the US FDA Label for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in the GWTG-HF Registry Vaduganathan, M., Greene, S., Zhang, S., Grau-Sepulveda, M. V., Devore, A. D., Butler, J., Heidenreich, P. A., Huang, J. C., Kittleson, M. M., Maddox, K., McDermott, J., Owens, A. T., Peterson, P., Solomon, S. D., Vardeny, O., Yancy, C. W., Fonarow, G. C. LIPPINCOTT WILLIAMS & WILKINS. 2020

View details for Web of Science ID 000607190405284